Phillip M. Schneider - 08 Nov 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director
Signature
/s/ Kathleen Scott, Attorney-in-Fact
Issuer symbol
SPRY
Transactions as of
08 Nov 2022
Net transactions value
$0
Form type
3
Filing time
10 Nov 2022, 16:01:19 UTC
Previous filing
31 May 2022
Next filing
26 May 2023

No securities are beneficially owned.